Strategies to Improve RTS,S-4 Uptake and Integration With Other Child Health Services

November 11, 2026 updated by: Simon Kariuki, Kenya Medical Research Institute

Investigating Approaches to Increase the Uptake of Malaria Vaccine and Other Childhood Health Interventions in Western Kenya: a Feasibility Study

This study will identify and evaluate innovative approaches to leverage malaria vaccine visits as opportunities to enhance the delivery of other child health services in Rarieda sub-county, Siaya County, Kenya where RTS,S became part of their routine childhood immunization programs in 2019. Using a human-centred design approach, the implementation research will be conducted in two phases.

Phase 1 (Diagnose and Design) will consist of formative research to understand current practices, barriers, and facilitators for childhood health and malaria interventions using the WHO's behavioural and social drivers' framework for immunization. Having identified the barriers and facilitators to uptake, the investigators will prioritize drivers and develop innovations for implementation in collaboration with communities, healthcare workers and managers.

Phase 2 (Implement and Evaluate) will focus on implementing and evaluating the innovations developed in Phase 1. Using the RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance) Framework, the study will assess the extent to which the interventions reach the target population, effectiveness of leveraging the malaria vaccine to increase uptake of other child health interventions, the extent of adoption by key stakeholders, and the fidelity and quality of implementation. The investigators will also explore cost and long-term sustainability.

The study will employ a mixed-methods approach, leveraging quantitative and qualitative data from health facility records, surveys, interviews, and observations.

The investigators will generate evidence on leveraging malaria vaccine visits and activities through: (i) innovative implementation strategies designed to maximize immunizations, child health interventions, and malaria prevention uptake; (ii) community engagement as an approach to optimize vaccine uptake and coverage; (iii) detailed qualitative data on the acceptability, perceptions, and barriers to uptake of vaccines and child health interventions; (iv) approaches to ensure access for zero-dose, under-vaccinated and underserved populations.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

2346

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Siaya, Kenya
        • Ong'ielo Health Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

  1. Primary caregivers of children eligible for malaria vaccination:

    • Inclusion criteria: Primary caregivers (age 18 years or older) of children who are eligible for or have received at least one dose of malaria vaccine
    • Exclusion criteria: Caregivers who are not the primary decision-makers for the child's healthcare or who have resided in the study area for less than 3 months
  2. Healthcare workers involved in immunization services:

    • Inclusion criteria: Clinical officers, nurses, or other healthcare staff directly involved in providing immunization services at the selected health facilities for at least 3 months
    • Exclusion criteria: Healthcare workers not involved in immunization service delivery or who have worked at the facility for less than 3 months
  3. Community health promoters (CHPs):

    • Inclusion criteria: CHPs working in the catchment areas of selected health facilities for at least 6 months
    • Exclusion criteria: CHPs who have not been active in the past 3 months
  4. Community members and leaders:

    • Inclusion criteria: community members and leaders willing to share their views on malaria vaccine barriers and facilitators, and approaches to improve uptake.
    • Exclusion criteria: Community members not willing to participate in the study
  5. Health facility managers and sub-county/county/national health officials:

    • Inclusion criteria: Health facility in-charges, sub-county or county EPI coordinators, and other relevant health officials overseeing immunization services across MoH hierarchy
    • Exclusion criteria: Officials who have been in their current position for less than 3 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: ITN - Provision of ITNs at RTS,S-4 visit

Leverage malaria vaccine to improve ITN access and use by providing ITNs at the 4th malaria dose visit, as well as vitamin A, deworming, MR2 and other missing vaccines

- At RTS,S-4 visit, health workers (HW) screen children for missing vaccinations and health services - HW provide catch-up vaccinations and services

Experimental: CHP - CHP identify and refer under-vaccinated children to health facility

Using malaria vaccine as an entry point, CHPs systematically identified under-vaccinated children during routine household visits and referred them to health facilities (HF), integrating immunization tracking into routine community activities.

  • CHP screen households for under-vaccinated children
  • CHP Provide referral for immunization
  • HW vaccinate referred children
  • HW provide catch-up vaccinations and services
  • CHP follow up on referral completion
Experimental: SMS - Enhanced defaulter tracing with use of mobile technology

Facility-community linkages were strengthened through CHP engagement and mobile phone-based reminders, including SMS notifications and defaulter tracing

  • HF diaries to record expected children on each date
  • HW record phone contacts in diaries to remind caregivers about visits (SMS or calls)
  • If caregivers cannot be reached, HW share contacts by SMS/WhatsApp with CHPs to trace defaulters at the house and provide referrals
  • HW screen & provide catch-up vaccinations & services
Experimental: SS - Strengthening immunization systems, health services, and interdepartmental collaboration

Multi-component intervention: 1) strengthening immunizations and health services through interdepartmental collaboration; 2) improving vaccine visit awareness, preparedness, and defaulter tracing; and 3) targeted monthly community outreaches, with CHPs mobilizing caregivers of children due or overdue for vaccination.

  • Screening children for vaccination status at triage
  • HW use colored ink to better visualize return dates in home-based records
  • HW Screen & provide catch-up vaccinations & services
  • CHPs trace defaulters, provide & follow up on referrals
  • HF diaries to record expected children on each date
  • HF conduct targeted community outreaches
  • CHP mobilize defaulters for scheduled outreaches

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reach
Time Frame: Three months

Vaccine coverage (%) in target populations and characteristics of vaccinated populations reached through study interventions

Three months
Effectiveness
Time Frame: Three months

Percentage increase in primary (dose 1-3) and booster (4th) doses post-interventions in age-eligible children

Three months
Adoption
Time Frame: Three months

Proportion of RTS,S vaccines provided concurrently with other vaccines/services.

Three months
Implementation
Time Frame: Three months

Perceived feasibility of interventions by health workers, caregivers, and community. A semi-structured interview guide will be used to assess implementation experiences.

Three months
Maintenance
Time Frame: Three months

Drivers of maintenance of interventions. A semi-structured interview guide will be used to elicit what it would take to continue implementing interventions beyond the study period.

Three months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: Simon Kariuki, PhD, Kenya Medical Research Institute
  • Principal Investigator: Nelli Westercamp, PhD, Centres for Disease Control and Prevention

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2025

Primary Completion (Actual)

December 4, 2025

Study Completion (Actual)

December 4, 2025

Study Registration Dates

First Submitted

October 22, 2026

First Submitted That Met QC Criteria

November 11, 2026

First Posted (Actual)

November 17, 2026

Study Record Updates

Last Update Posted (Actual)

November 17, 2026

Last Update Submitted That Met QC Criteria

November 11, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • KEMRI/SERU/CGHR/537/5206

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Only aggregated data is required for reports and manuscripts.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.